Pathophysiology and management of portal hypertension 2: Cirrhotic ascites

British Journal of Hospital Medicine

Volumn 58, Issue 2-3, 1997, Pages 74-78

  Stanley, Adrian J ^a,b   Bouchier, Lan A D ^a   Hayes, Peter C ^a  

^a Department of Medicine ^*  (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

ASCITES; HUMAN; KIDNEY DISEASE; LIVER CIRRHOSIS; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; REVIEW; SODIUM RESTRICTION;

ASCITES; DIET, SODIUM-RESTRICTED; DIURETICS; HUMANS; HYPERTENSION, PORTAL; KIDNEY DISEASES; LIVER CIRRHOSIS;

EID: 0031560987     PISSN: 00071064     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Altinan C, Grange JD, Amiot X et al (1995) Survival after a first episode of spontaneous bacterial peritonitis: prognosis of potential candidates for orthotopic liver transplantation. J. Gastroenterol Hcpatol 10: 47-50
2. Andrcu M, Sola R, Sitges-Serra A et al (1993) Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Castroentcroloey 104: 1133-8
3. Arroyo V, Gmes P (1991) Renal function abnormalities in cirrhosis. EurJ Gastroenterol Hepatol 3: 714-20
4. Arroyo V, Bosch J, Mauri M et al (1979) Renin, aldostcrone and renal haemodynamics in cirrhosis with ascites. Eur J. Clin Invest 9: 69-73
5. Arroyo V, Gines P, Planas R et al (1986) Management of patients with cirrhosis and ascites. Sem Liv Dis 6: 353-63
6. Arroyo V, Gines P, Gerbes AL et al (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23: 164-76
7. Baq Y, Gaudin C, Hadengue A et al (1991) Systemic, splanchnic and renal haemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology 14: 483-7
8. Fassio E, Tery R, Landeira G et al (1992) Paracentesis with dextran 70 vs paracentesis with albumin in cirrhosis with tense ascites. J. Hepatol 14: 310-6
9. Forrest E, Stanley AJ, Redhead DN et al (1996) Clinical response after transjugular intrahepatic portosystemic stent-shunt insertion for refractory ascites in cirrhosis. Aliment Pharmacol Tberapeut 10: 801-6
10. Gerbes AL (1993) Medical treatment of ascites in cirrhosis. J. Hepatol 17:54-9
11. Jimenez W, Martinez-Pardo A, Arroyo V et al (1985) Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis. Effect of spironolactone. Hepatology 5: 245-50
12. Lebrec D, Giuily N, Hadengue A et al (1996) Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomised trial. J. Hepatol 25: 135-44
13. Ochs A, Rossle M, Haag K et al (1995) The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N EnglJ Med 332:1192-7
14. Perez-Ayuso RM, Arroyo V, Planas R et al (1983) Randomized comparative study of efficacy of furosemide vs spironolactone in non-azotemic cirrhosis with ascites. Gastroenterology 84: 961-8
15. Runyon BA (1988) Spontaneous bacterial peritonitis: an explosion of information. Hepatology 8: 171-5
16. Salerno F, Badalamenti S, Lorenzano et al (1991) Randomized comparative study of hemaccel vs albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 13: 707-13
17. Schrier RW, Arroyo V, Bernardi M et al (1988) Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151-7
18. Shear L, Chmg S, Gabuzda GJ (1970) Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N EnglJ Med 232: 1391-6
19. Soriano G, Guarner C, Tomas A et al (1992) Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal haemorrhage. Gastroenterology 103: 1267-72